SG11201402902VA - Mammalian fetal pulmonary cells and therapeutic use of same - Google Patents
Mammalian fetal pulmonary cells and therapeutic use of sameInfo
- Publication number
- SG11201402902VA SG11201402902VA SG11201402902VA SG11201402902VA SG11201402902VA SG 11201402902V A SG11201402902V A SG 11201402902VA SG 11201402902V A SG11201402902V A SG 11201402902VA SG 11201402902V A SG11201402902V A SG 11201402902VA SG 11201402902V A SG11201402902V A SG 11201402902VA
- Authority
- SG
- Singapore
- Prior art keywords
- same
- therapeutic use
- pulmonary cells
- mammalian fetal
- fetal pulmonary
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0688—Cells from the lungs or the respiratory tract
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Developmental Biology & Embryology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Microbiology (AREA)
- Physiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161568240P | 2011-12-08 | 2011-12-08 | |
| PCT/IB2012/057042 WO2013084190A1 (fr) | 2011-12-08 | 2012-12-06 | Cellules pulmonaires fœtales de mammifères et leur utilisation thérapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201402902VA true SG11201402902VA (en) | 2014-07-30 |
Family
ID=47557423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201402902VA SG11201402902VA (en) | 2011-12-08 | 2012-12-06 | Mammalian fetal pulmonary cells and therapeutic use of same |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9833482B2 (fr) |
| EP (2) | EP2788009B1 (fr) |
| JP (1) | JP2015500279A (fr) |
| KR (1) | KR20140102730A (fr) |
| CN (1) | CN104105493A (fr) |
| AU (1) | AU2012348574A1 (fr) |
| CA (1) | CA2857930A1 (fr) |
| ES (2) | ES2587876T3 (fr) |
| HK (1) | HK1202809A1 (fr) |
| HU (1) | HUE030541T2 (fr) |
| IL (1) | IL233022A (fr) |
| MX (1) | MX2014006756A (fr) |
| PH (1) | PH12014501309A1 (fr) |
| PL (1) | PL2788009T3 (fr) |
| PT (1) | PT2788009T (fr) |
| RU (1) | RU2014127338A (fr) |
| SG (1) | SG11201402902VA (fr) |
| WO (1) | WO2013084190A1 (fr) |
| ZA (1) | ZA201404958B (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012305931B2 (en) | 2011-09-08 | 2017-09-07 | Yeda Research And Development Co. Ltd | Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment |
| CN104105493A (zh) | 2011-12-08 | 2014-10-15 | 耶达研究及发展有限公司 | 哺乳动物胎儿肺细胞以及其治疗用途 |
| CN104977414B (zh) * | 2014-04-09 | 2016-09-28 | 上海交通大学医学院 | 鉴定骨髓中是否存在保护白血病干细胞微环境的试剂盒及其应用 |
| US10668109B2 (en) | 2015-06-18 | 2020-06-02 | Yeda Research And Development Co. Ltd. | Conditioning protocols and use of same for tissue regeneration |
| DK3322425T3 (da) | 2015-07-16 | 2023-06-12 | Yeda Res & Dev | Genmodificerede anti-tredjeparts-centralhukommelse-t-celler og brug af samme i immunterapi |
| EP3463402B1 (fr) * | 2016-05-22 | 2021-06-23 | Yeda Research and Development Co. Ltd. | Méthodes d'utilisation de cellules pulmonaires pour transplantation et induction de tolérance |
| US10751368B2 (en) | 2017-01-18 | 2020-08-25 | Yeda Research And Development Co. Ltd. | Methods of transplantation and disease treatment |
| US11555178B2 (en) | 2017-01-18 | 2023-01-17 | Yeda Research And Development Co. Ltd. | Genetically modified veto cells and use of same in immunotherapy |
| CN111727238B (zh) * | 2017-10-27 | 2024-06-25 | 阿里斯制药有限公司 | 非人动物胎儿组织提取物、生产提取物的方法及其用途 |
| CN109529123B (zh) * | 2018-11-08 | 2021-02-19 | 中国人民解放军第四军医大学 | 水凝胶、纳米纤维支架与皮肤细胞层层组装的血管化全层组织工程皮肤及其制备方法 |
| EP3747992A1 (fr) | 2019-06-04 | 2020-12-09 | Medizinische Hochschule Hannover | Compositions et procédé d'intégration de cellules dans l'épithélium |
| CN111518761B (zh) * | 2020-05-25 | 2022-04-29 | 青岛瑞思德生物科技有限公司 | 一种间充质干细胞体外筛选、激活、扩增、冻存及其细胞库建立的方法 |
| WO2023105526A1 (fr) | 2021-12-08 | 2023-06-15 | Yeda Research And Development Co. Ltd. | Cellules progénitrices pulmonaires multipotentes pour la régénération pulmonaire |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| NL154599B (nl) | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
| US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
| US3853987A (en) | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
| US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| NL171930C (nl) | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
| US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
| US3935074A (en) | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4034074A (en) | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
| US3984533A (en) | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
| US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
| US4879219A (en) | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
| US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5004681B1 (en) | 1987-11-12 | 2000-04-11 | Biocyte Corp | Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
| US5192553A (en) | 1987-11-12 | 1993-03-09 | Biocyte Corporation | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| US5281521A (en) | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
| DE69534151T2 (de) | 1994-02-22 | 2006-01-12 | Nippon Telegraph And Telephone Corp. | Gefriergetrocknete Blutzellen, Stammzellen und Plättchen und Verfahren zu deren Herstellung |
| US6204053B1 (en) * | 1994-11-08 | 2001-03-20 | Diacrin, Inc. | Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| US6110459A (en) | 1997-05-28 | 2000-08-29 | Mickle; Donald A. G. | Transplants for myocardial scars and methods and cellular preparations |
| US5955257A (en) | 1997-10-21 | 1999-09-21 | Regents Of The University Of Minnesota | Infusible grade short-term cell storage medium for mononuclear cells |
| US8609412B2 (en) * | 1999-08-05 | 2013-12-17 | Regents Of The University Of Minnesota | Mapc generation of lung tissue |
| EP1099754A1 (fr) * | 1999-11-10 | 2001-05-16 | Universiteit Leiden | Cellules souches mesenchymateuses et/ou cellules progénitrices, leur isolation et leur utilisation |
| US20040136972A1 (en) | 2001-09-07 | 2004-07-15 | Yeda Research And Development Co. Ltd. | Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues |
| US20030096016A1 (en) * | 2001-09-07 | 2003-05-22 | Yeda Research And Development Co. Ltd. | Methods of kidney transplantation utilizing developing nephric tissue |
| US20030215942A1 (en) | 2002-02-14 | 2003-11-20 | Stemcyte, Inc. | Undesignated allogeneic stem cell bank |
| IL164048A0 (en) | 2002-03-15 | 2005-12-18 | Univ North Carolina | Primitive and proximal hepatic stemcells |
| GB0304799D0 (en) | 2003-03-03 | 2003-04-09 | Glaxosmithkline Biolog Sa | Novel method |
| AU2005290849B2 (en) | 2004-10-04 | 2009-09-03 | Yeda Research And Development Co. Ltd. | Disease treatment via developing non-syngeneic graft transplantation |
| US8628964B2 (en) * | 2006-10-11 | 2014-01-14 | Drexel University | Fetal pulmonary cells and uses thereof |
| US20100034791A1 (en) * | 2007-02-14 | 2010-02-11 | Drexel University | Engineered Lung Tissue Construction for High Throughput Toxicity Screening and Drug Discovery |
| US9534204B2 (en) * | 2010-10-05 | 2017-01-03 | Aal Scientifics, Inc. | Human lung stem cells and uses thereof |
| CN104105493A (zh) | 2011-12-08 | 2014-10-15 | 耶达研究及发展有限公司 | 哺乳动物胎儿肺细胞以及其治疗用途 |
| US10434121B2 (en) | 2011-12-22 | 2019-10-08 | Yeda Research And Development Co. Ltd. | Combination therapy for a stable and long term engraftment using specific protocols for T/B cell depletion |
| US10668109B2 (en) | 2015-06-18 | 2020-06-02 | Yeda Research And Development Co. Ltd. | Conditioning protocols and use of same for tissue regeneration |
-
2012
- 2012-12-06 CN CN201280069291.9A patent/CN104105493A/zh active Pending
- 2012-12-06 EP EP12813990.4A patent/EP2788009B1/fr active Active
- 2012-12-06 AU AU2012348574A patent/AU2012348574A1/en not_active Abandoned
- 2012-12-06 CA CA2857930A patent/CA2857930A1/fr not_active Abandoned
- 2012-12-06 MX MX2014006756A patent/MX2014006756A/es unknown
- 2012-12-06 SG SG11201402902VA patent/SG11201402902VA/en unknown
- 2012-12-06 US US14/363,814 patent/US9833482B2/en active Active
- 2012-12-06 ES ES12813990.4T patent/ES2587876T3/es active Active
- 2012-12-06 ES ES16151376.7T patent/ES2673471T3/es active Active
- 2012-12-06 HU HUE12813990A patent/HUE030541T2/en unknown
- 2012-12-06 PL PL12813990.4T patent/PL2788009T3/pl unknown
- 2012-12-06 JP JP2014545442A patent/JP2015500279A/ja active Pending
- 2012-12-06 WO PCT/IB2012/057042 patent/WO2013084190A1/fr active Application Filing
- 2012-12-06 EP EP16151376.7A patent/EP3034087B1/fr active Active
- 2012-12-06 KR KR1020147018702A patent/KR20140102730A/ko not_active Application Discontinuation
- 2012-12-06 RU RU2014127338A patent/RU2014127338A/ru not_active Application Discontinuation
- 2012-12-06 PT PT128139904T patent/PT2788009T/pt unknown
-
2014
- 2014-06-08 IL IL233022A patent/IL233022A/en active IP Right Grant
- 2014-06-09 PH PH12014501309A patent/PH12014501309A1/en unknown
- 2014-07-07 ZA ZA2014/04958A patent/ZA201404958B/en unknown
-
2015
- 2015-04-08 HK HK15103466.2A patent/HK1202809A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140102730A (ko) | 2014-08-22 |
| EP2788009B1 (fr) | 2016-05-25 |
| US20140356335A1 (en) | 2014-12-04 |
| EP2788009A1 (fr) | 2014-10-15 |
| US9833482B2 (en) | 2017-12-05 |
| NZ627071A (en) | 2015-11-27 |
| EP3034087B1 (fr) | 2018-03-14 |
| HUE030541T2 (en) | 2017-05-29 |
| JP2015500279A (ja) | 2015-01-05 |
| MX2014006756A (es) | 2015-03-09 |
| CA2857930A1 (fr) | 2013-06-13 |
| EP3034087A1 (fr) | 2016-06-22 |
| ES2587876T3 (es) | 2016-10-27 |
| RU2014127338A (ru) | 2016-02-10 |
| CN104105493A (zh) | 2014-10-15 |
| PL2788009T3 (pl) | 2016-11-30 |
| AU2012348574A1 (en) | 2014-07-24 |
| HK1202809A1 (en) | 2015-10-09 |
| ES2673471T3 (es) | 2018-06-22 |
| PT2788009T (pt) | 2016-08-31 |
| PH12014501309A1 (en) | 2014-09-15 |
| IL233022A (en) | 2017-12-31 |
| WO2013084190A1 (fr) | 2013-06-13 |
| ZA201404958B (en) | 2015-05-27 |
| IL233022A0 (en) | 2014-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1202809A1 (en) | Mammalian fetal pulmonary cells and therapeutic use of same | |
| HK1251617A1 (zh) | 表達cd40l的哺乳動物細胞及其用途 | |
| HK1249548A1 (zh) | 用於無脈絡膜的基因療法的aav載體 | |
| HK1210494A1 (zh) | 用於細胞培養的裝置和方法 | |
| HK1198262A1 (en) | Measuring volume and constituents of cells | |
| PT2683815E (pt) | Derivados de piridinona como inibidores da transglutaminase tecidular | |
| EP2736837A4 (fr) | Matières actives nanostructurées de batterie et procédés de production correspondants | |
| PT3527584T (pt) | Recetores de célula t anti-ny-eso-1 murinos | |
| SG2014011282A (en) | Anode battery materials and methods of making the same | |
| EP2638149A4 (fr) | Immortalisation de cellules épithéliales et leurs procédés d'utilisation | |
| EP2591797A4 (fr) | Facteur de régulation de foxp3 et de lymphocytes t régulateurs et son utilisation | |
| PL3321355T3 (pl) | Sposoby i kompozycje do klinicznego pozyskiwania komórek alogenicznych oraz zastosowania terapeutyczne | |
| GB201100180D0 (en) | Tumour cell and tissue culture | |
| IL226666B (en) | Methods of generating corneal cells and cell populations comprising same | |
| EP2606123A4 (fr) | Procédés de générations d'oligodentrocytes et de populations cellulaires les comprenant | |
| EP2555801A4 (fr) | Sélection et utilisation de cellules hôte pour la production de glycoprotéines | |
| EP2714709A4 (fr) | Procédés basés sur des cellules et des gènes permettant d'améliorer la fonction cardiaque | |
| SG11201502497RA (en) | Sebocyte cell culturing and methods of use | |
| EP2616073A4 (fr) | Inhibiteurs d'entrée virale dans des cellules de mammifères | |
| SG11201401038VA (en) | Isolating and therapeutic use of perivascular medicinal cells | |
| BR112014014033A2 (pt) | células pulmonares fetais de mamíferos e uso terapêutico das mesmas |